A 2nd-generation scalable synthesis of the HIV-1 entry inhibitor CJF-III-288 enabled by photoredox catalysis
Abstract
The development and optimization of a 2nd-Generation process synthesis for the human immunodeficiency virus-1 entry inhibitor CJF-III-288 bis-trifloroacetate salt 1 is reported. The route eliminates the use of noble metals, decreases the step count nearly by half, and increases the overall yield tenfold.
Fields of Study & Subjects
Radical Photochemical Reactions
HIV/AIDS drug development and treatment
Sulfur-Based Synthesis Techniques
Publication details
- Journal / source
- Chemical Communications
- Volume
- 62
- Issue
- 9
- Pages
- 2981–2985
- Publication date
- 1 January 2026
- Language
- EN